NCT01930357View on ClinicalTrials.gov

Purified Vero Rabies Vaccine-Serum Free Compared to Human Diploid Cell Vaccine in a Pre-exposure Prophylaxis Regimen

PHASE2CompletedINTERVENTIONAL
Enrollment

342

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

June 30, 2015

Conditions
Rabies
Interventions
BIOLOGICAL

Purified Vero Rabies Vaccine Serum Free (VRVg)

0.5 mL, Intramuscular (Day 0, Day 7 and Day 28).

BIOLOGICAL

Imovax® Rabies: Human Diploid Cell Vaccine (HDCV),

0.5 mL, Intramuscular (Day 0, Day 7 and Day 28).

Trial Locations (2)

1000

Manila

1781

City of Muntinlupa

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT01930357 - Purified Vero Rabies Vaccine-Serum Free Compared to Human Diploid Cell Vaccine in a Pre-exposure Prophylaxis Regimen | Biotech Hunter | Biotech Hunter